Allianz Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$907K Buy
17,000
+4,200
+33% +$224K ﹤0.01% 1275
2025
Q1
$518K Buy
+12,800
New +$518K ﹤0.01% 1410